Trial of intravenous nafamostat mesylate in COVID pneumonitis:

COVID research is a focus area at the moment, and it's great to see the ClotPro being used in the UK using the #TPA-test: assessment of coagulation with fibrinolysis activation (using recombinant tissue plasminogen activator) and custom panel evaluating anticoagulant activity with the #RVV-test #research #covid #Clotpro

https://lnkd.in/gtaTtQGC